Showing results (1371-1380 of 1,686) with videos related to

Sort By:
Pageof 169
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 22, 2025
Impact of diabetes in long-term outcomes following intravascular brachytherapy for in-stent restenosisMangesh Kritya, Gal Sella, Chloe Kharsa, et al.
Circulation|October 1, 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplastyJ E Tcheng, S G Ellis, B S George, et al.
The American Journal of Cardiology|May 8, 2012
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry)Ronald P Caputo, Ankush Goel, Michael Pencina, et al.
Lancet (London, England)|January 15, 2000
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingE J Topol, D B Mark, A M Lincoff, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 1, 2021
Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD)James E Galvin, Stephanie Chrisphonte, Iris Cohen, et al.
JAMA Cardiology|June 22, 2017
Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT RegistryRavi S Hira, Sreekanth Vemulapalli, Zhuokai Li, et al.
Anesthesiology|October 27, 2020
Anesthesiologist Age and Sex Influence Patient Perceptions of Physician CompetenceKatherine T Forkin, Lauren K Dunn, Naveen C Kotha, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 26, 2015
Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesisWalid K Abu Saleh, Gilbert H L Tang, Hasan Ahmad, et al.
JACC. Cardiovascular Interventions|September 21, 2019
Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT RegistryAndres M Pineda, J Kevin Harrison, Neal S Kleiman, et al.
Circulation|February 21, 2002
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trialMichael Simons, Brian H Annex, Roger J Laham, et al.
Pageof 169